Lung Therapeutics, based in Austin, Texas, is a leading biopharmaceutical company focused on advancing first-in-class therapies for underserved fibrosis and lung diseases.
With a highly promising product pipeline featuring two leading programs, LTI-01 and LTI-03, Lung Therapeutics aims to provide better treatment options for patients suffering from life-threatening fibrosis and lung conditions.
Generated from the website